Antithymocyte globulin for patients with myelodysplastic syndrome

British Journal of Haematology

Volumn 99, Issue 3, 1997, Pages 699-705

  Molldrem, Jeffrey J ^a,b   Caples, Mary ^a   Mavroudis, Dimitrios ^a   Plante, Michelle ^a   Young, Neal S ^a   Barrett, A John ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Immunosuppression; Myelodysplastic syndrome; Myeloid leukaemia; Refractory anaemia; Treatment

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; DANAZOL; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; INTERLEUKIN 3; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISONE; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; SERUM SICKNESS; SURVIVAL RATE;

EID: 0030695069     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.4423249.x     Document Type: Article

References (35)

1. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. & Sultan, C. (1982) Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189-199.
2. Bernstein, S.H., Brunetto, V.L., Davey, E.R., Wurster-Hill, D., Mayer, R.J., Stone, R.M., Schiffer, C.A. & Bloomfield, C.D. (1996) Acute myeloid leukemia-type chemotherapy for newly diagnosed patients without antecedent cytopenias having myelodysplastic syndrome as defined by French-American-British criteria: a Cancer and Leukemia Group B study. Journal of Clinical Oncology, 14, 2486-2494.
3. Bielory, L., Wright, R., Nienhuis, A.W., Young, N.S. & Kaliner, M.A. (1988) Antithymocyte globulin hypersensitivity in bone marrow failure patients. Journal of the American Medical Association, 260, 3164-3167.
4. Champlin, R., Ho, W. & Gale, R.P. (1983) Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial. New England Journal of Medicine, 308, 113-118.
5. Cheson, B.D., Jasperse, D.M., Simon, R. & Friedman, M.A. (1986) A critical appraisal of low dose cytosine arabinoside in patients with acute non-lymphocytic leukaemia and myelodysplastic syndromes. Journal of Clinical Oncology, 4, 1857-1864.
6. Coiffier, B., Adeleine, P., Viala, J.J., Bryon, P.A., Fiere, D., Gentilhomme, O. & Vuvan, H. (1983) Dysmyelopoietic syndromes: a search for prognostic factors in 193 patients. Cancer, 52, 83-90.
7. Foucar, K., Langdon, R.M., Armitage, J.O., Olson, D.B. & Carroll, T.J., Jr (1985) Myelodysplastic syndromes: a clinical and pathologic analysis of 109 cases. Cancer, 56, 553-561.
8. Greenberg, P.L. (1986) In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders. Clinical Haematology, 15, 973-993.
9. Hasle, H. (1994) Myelodysplastic syndromes in childhood: classification, epidemiology, and treatment. Leukemia and Lymphoma, 13, 11-26.
10. Hasle, H., Jacobsen, B.B. & Pedersen, N.T. (1992) Myelodysplastic syndromes in childhood: a population based study of nine cases. British Journal of Haematology, 81, 495-448.
11. Hasle, H., Kerndrup, G., Yssing, M., Clausen, N., Ostergaard, E., Jacobsen, N. & Jacobsen, B.B. (1996) Intensive chemotherapy in childhood myelodysplastic syndrome: a comparison with results in acute myeloid leukemia. Leukemia, 10, 1269-1273.
12. Hirst, W.J.R. & Mufti, G.J. (1995) Management of myelodysplastic syndromes. British Journal of Haematology, 84, 191-196.
13. Janssen, J.W., Buschle, M., Layton, M., Drexler, H.G., Lyons, J., van den Berghe, H., Heimpel, H., Kubanek, B., Kleihauer, E., Mufti, G.J. & Bartram, C.R. (1989) Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin. Blood, 73, 248-254.
14. Kouides, P.A. & Bennett, J.M. (1992) Morphology and classification of myelodysplastic syndromes. Hematology/Oncology Clinics of North America, 6, 485-499.
15. Mecucci, C. & Van den Berghe, H. (1992) Cytogenetics. Hematology/Oncology Clinics of North America, 6, 523-541.
16. Miescher, P.A., Favre, H. & Beris, P. (1991) Autoimmune myelodysplasias. Seminars in Hematology, 28, 322-330.
17. Mineishi, S., Filippa, D., Childs, B. & Castro-Melaspina, H. (1994) Hypoplastic myelodysplastic syndrome (MDS): clinical, hematologic, and pathologic observations in 36 cases. Blood, 84, 1245.
18. Mookerjee, B.K., Azzolina, L. & Poultar, L. (1974) Interaction of anti-thymocyte serum with hematopoietic stem cells. I. Effects in vitro and in vivo. Journal of Immunology, 112, 822-829.
19. Mufti, G.J. & Galton, D.A. (1986) Myelodysplastic syndromes: natural history and features of prognostic importance. Clinical Haematology, 15, 953-971.
20. Najean, Y. & Pecking, R. (1977) Refractory anaemia with excess myeloblasts in the bone marrow: a clinical trial of androgens in 90 patients. British Journal of Haematology, 37, 25-33.
21. Nand, S., Sosman, J., Godwin, J.E. & Fisher, R.I. (1944) A phase I/II study of sequential interleukin-3 and granulocyte-macrophage colony-stimulating factor in myelodysplastic syndromes. Blood, 83, 357-360.
22. Negrin, R.S., Stein, R., Doherty, K., Cornwell, J., Vardiman, J., Krantz, S. & Greenberg, P.L. (1996) Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergy. Blood, 87, 4076-4081.
23. Nimer, S.D., Golde, D.W., Kwan, K., Lee, K., Clark, S. & Champlin, R. (1991) In vitro production of granulocyte-macrophage colony-stimulating factor in aplastic anemia: possible mechanisms of action of antithymocyte globulin. Blood, 78, 163-168.
24. Nimer, S.D., Paquette, R.L., Ireland, P., Resta, D., Young, D. & Golde, D.W. (1994) A phase I/II study of interleukin-3 in patients with aplastic anemia and myelodysplasia. Experimental Hematology, 22, 875-880.
25. Ohno, R. (1994) Differentiation therapy of myelodysplastic syndromes with retinoic acid. Leukemia and Lymphoma, 14, 401-409.
26. Passmore, S.J., Hann, I.M., Stiller, C.A., Ramani, P., Swansbury, G.J., Gibbons, B., Reeves, B.R. & Chessells, J.M. (1995) Pediatric myelodysplasia: a study of 68 children and a new prognostic scoring system. Blood, 85, 1742-1750.
27. Sanz, G.F., Sanz, M.A., Vallespi, T., Canizo, M.C., Torrabadella, M., Garcia, S., Irriguible, D. & San Miguel, J.F. (1989) Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood, 74, 395-408.
28. Smith, M.A. & Smith, J.G. (1991) The occurrence, subtype and significance of haemopoietic inhibitory T cells (HIT cells) in myelodysplasia: an in vitro study. Leukemia Research, 15, 597-601.
29. Sugawara, T., Endo, K., Shishido, T., Sato, A., Kameoka, J., Fukuhara, O., Yoshinaga, K. & Miura, A. (1992) T-cell-mediated inhibition of erythropoiesis in myelodysplastic syndromes. (Letter). American Journal of Hematology, 41, 304-305.
30. Sulecki, M., Shadduck, R.K. & Zeigler, Z. (1988) Anti-thymocyte globulin for hypoplastic myelodysplastic syndrome. Blood, 72, 229A.
31. Tichelli, A., Gratwohl, A., Wuersch, A., Nissen, C. & Speck, B. (1988) Antilymphocyte globulin for myelodysplastic syndrome? British Journal of Haematology, 68, 139.
32. Tuzuner, N., Cox, C., Rowe, J.M., Watrous, D. & Bennett, J.M. (1995) Hypocellular myelodysplastic syndromes (MDS): new proposals. British Journal of Haematology, 91, 612-617.
33. Young, N., Griffith, P., Brittain, E., Elfenbein, G., Gardner, F., Huang, A., Harmon, D., Hewlett, J., Fay, J., Mangan, K., Morrison, F., Sensenbrenner, L., Shadduck, R., Wang, W., Zaroulis, C. & Zuckerman, K. (1988) A multicenter trial of antithymocyte globulin in aplastic anemia and related diseases. Blood, 72, 1861-1869.
34. Yunis, J.J. & Brunning, R.D. (1986) Prognostic significance of chromosomal abnormalities in acute leukaemias and myelodysplastic syndromes. Clinical Haematology, 15, 597-620.
35. Yunis, J.J., Lobell, M., Arnesen, M.A., Oken, M.M., Mayer, M.G., Rydell, R.E. & Brunning, R.D. (1988) Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia. British Journal of Haematology 68, 189-194.